rd postoperative day, the patients with thrombosis risk undergo a follow-up examination – ultrasound Doppler ultrasonography (USDU), if necessary, adjusting the dose of sodium enoxaparin, on 5th postoperative day, analyzes are carried out: coagulogram, D-dimers, FBC, "Thrombodynamics", with a high risk of thrombosis on 3rd-4th day, USDU vein of lower extremities is administered, and if thrombosis or thrombosis of any localization is prescribed therapeutic doses of heparin, if USDU is determined by the presence of thrombosis with signs of flotation – thrombectomy.;EFFECT: technical result of the invention is reducing the risk of TEC.;1 cl, 13 dwg, 3 ex"/> METHOD FOR PREVENTING THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH MULTIPLE FRACTURES OF LIMB LONG BONES
首页> 外国专利> METHOD FOR PREVENTING THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH MULTIPLE FRACTURES OF LIMB LONG BONES

METHOD FOR PREVENTING THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH MULTIPLE FRACTURES OF LIMB LONG BONES

机译:预防肢体长骨骨折的血栓性双系并发症的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to traumatology, and represents a method for prevention of thromboembolic complications (TEC) in patients with multiple fractures of limb long bones, differing by the fact that after patient withdrawal from traumatic shock, stabilization of hemodynamics values and analysis of "Trombodynamics" in case of bleeding development threat, preoperative preparation is performed without anticoagulant, in the absence of signs of hypercoagulation, sodium enoxaparin is administered to a patient in a standard dosage of 40 mg, with hypercoagulation, with a fibrin clot growth rate greater than 29 mcm/min, dosage is increased to 60 mg, in severe cases, with the formation of spontaneous clots, sodium enoxaparin dose is increased to 80 mg a day, on 3rd postoperative day, the patients with thrombosis risk undergo a follow-up examination – ultrasound Doppler ultrasonography (USDU), if necessary, adjusting the dose of sodium enoxaparin, on 5th postoperative day, analyzes are carried out: coagulogram, D-dimers, FBC, "Thrombodynamics", with a high risk of thrombosis on 3rd-4th day, USDU vein of lower extremities is administered, and if thrombosis or thrombosis of any localization is prescribed therapeutic doses of heparin, if USDU is determined by the presence of thrombosis with signs of flotation – thrombectomy.;EFFECT: technical result of the invention is reducing the risk of TEC.;1 cl, 13 dwg, 3 ex
机译:技术领域本发明涉及医学,即创伤学,并且代表一种预防肢体长骨多处骨折的患者的血栓栓塞并发症(TEC)的方法,其不同之处在于患者从创伤性休克中退出后,稳定血流动力学值并在发生出血威胁的情况下进行“血流动力学”分析,术前准备时不使用抗凝剂,在无高凝迹象的情况下,依诺肝素钠以40毫克的标准剂量给予患者,伴高凝,在纤维蛋白凝块生长速率大于29 mcm / min的情况下,剂量增加至60 mg,在严重的情况下,随着自发性凝块的形成,依诺肝素钠的剂量每天增加至80 mg,第3次。 Sup>术后一天,有血栓形成风险的患者接受随访检查–超声多普勒超声检查(USDU),必要时调整依诺沙普钠剂量术后第5天的Arin进行分析:血凝图,D-二聚体,FBC,“血栓动力学”,在3 rd -4处有血栓形成的高风险 日,给予下肢USDU静脉,如果规定血栓形成或任何局部血栓形成的治疗剂量为肝素,如果USDU是由存在浮选迹象的血栓形成确定的,则应行血栓切除术。效果:本发明的技术结果是降低了TEC的风险。1cl,13 dwg,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号